Your Article Summary
New Data Suggest that GELNIQUE(R) gel 10% Does Not Impact Cognition among Healthy Older Adults
Watson Pharmaceuticals, 09/30/09
Watson Pharmaceuticals, Inc., a leader in generic and specialty branded pharmaceuticals, announced findings of a double–blind study which demonstrate that GELNIQUE was comparable to placebo in its effect on memory tests and other cognitive functions in older healthy adult subjects when compared to immediate release oral oxybutynin treatments. The results were presented at the International Continence Society's Annual Meeting.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor


See Latest Articles


